Skip to main content
Top
Published in: BMC Surgery 1/2015

Open Access 01-12-2015 | Research article

Long-term prognosis after resection of cryptogenic hepatocellular carcinoma

Authors: Yu Ohkura, Kazunari Sasaki, Masamichi Matsuda, Masaji Hashimoto, Goro Watanabe

Published in: BMC Surgery | Issue 1/2015

Login to get access

Abstract

Background

We investigated the patterns and predictors of recurrence and survival in cryptogenic non-B, non-C, non-alcoholic hepatocellular carcinoma (CR-HCC). We compared the findings with those hepatitis virus B (B) and hepatitis virus C (C)-HCC. CR-HCC does not include HCC developed on NASH.

Methods

From 1990 to 2011, of 676 patients who underwent primary curative liver resection as initial therapy for HCC at our institution, 167 had B-HCC, 401 had C-HCC, and 62 had CR-HCC. Differences between three groups were analyzed using the Chi-squared test. Cumulative overall survival (OS) and disease-free survival (DFS) were determined by the Kaplan-Meier method, prognostic factors involved in OS/DFS were evaluated by univariate analysis using the log-rank test, and stepwise Cox regression analysis.

Results

Liver function was better in CR-HCC than in B/C-HCC, and mean tumor size was larger in CR-HCC than in B/C-HCC. In CR-HCC, OS was equivalent to that of B/C-HCC, and DFS was equivalent to that of B-HCC. Both tumor-related factors and background liver function appeared to be prognostic factors for three groups.

Conclusion

Our findings indicate that the probability of survival of advanced CR-HCC was not longer than that of B/C-HCC. Given our findings, a postoperative follow-up protocol for CR-HCC should be established alongside that for B/C-HCC.
Literature
1.
go back to reference Utsunomiya T, Shimada M, Kudo M, Ichida T, Matsui O, Izumi N, et al. Nationwide study of 4741 patients with Non-B Non-C hepatocellular carcinoma with special reference to the therapeutic impact. Ann Surg. 2013;00:1–10. Utsunomiya T, Shimada M, Kudo M, Ichida T, Matsui O, Izumi N, et al. Nationwide study of 4741 patients with Non-B Non-C hepatocellular carcinoma with special reference to the therapeutic impact. Ann Surg. 2013;00:1–10.
2.
go back to reference Ikai I, Arii S, Okazaki M, Okita K, OmataM KM, Takayasu K, et al. Report of the 17 th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2007;37:676–91.CrossRefPubMed Ikai I, Arii S, Okazaki M, Okita K, OmataM KM, Takayasu K, et al. Report of the 17 th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2007;37:676–91.CrossRefPubMed
3.
go back to reference Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 3rd ed. Tokyo: Kanehara; 2010. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 3rd ed. Tokyo: Kanehara; 2010.
4.
go back to reference Hirohashi S, Blum HE, Ishak KG. Tumours of the liver and intrahepatic bile ducts. In: Hamilton SR, Aaltonen LA, editors. World Health Organisation classification of tumours: pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. p. 157–202. Hirohashi S, Blum HE, Ishak KG. Tumours of the liver and intrahepatic bile ducts. In: Hamilton SR, Aaltonen LA, editors. World Health Organisation classification of tumours: pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. p. 157–202.
5.
go back to reference Tanaka H, Imai Y, Hiramatsu N, Hiramatsu N, Ito Y, Imanaka K, et al. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med. 2008;148:820–6.CrossRefPubMed Tanaka H, Imai Y, Hiramatsu N, Hiramatsu N, Ito Y, Imanaka K, et al. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med. 2008;148:820–6.CrossRefPubMed
7.
go back to reference Tateishi R, Okanoue T, Fujiwara N, Okita K, Kiyosawa K, Omata M, et al. Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study. J Gastroenterol. 2014;50(3):350–60.PubMedCentralCrossRefPubMed Tateishi R, Okanoue T, Fujiwara N, Okita K, Kiyosawa K, Omata M, et al. Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study. J Gastroenterol. 2014;50(3):350–60.PubMedCentralCrossRefPubMed
8.
go back to reference Heneghan MA, McFarlane IG. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology. 2002;35:7–13.CrossRefPubMed Heneghan MA, McFarlane IG. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology. 2002;35:7–13.CrossRefPubMed
9.
go back to reference Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998;33:99–103.CrossRefPubMed Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998;33:99–103.CrossRefPubMed
11.
go back to reference Nanashima A, Abo T, Sumida Y, Takeshita H, Hidaka S, Furukawa K, et al. Clinicopathological characteristics of patients with hepatocellular carcinoma after hepatectomy: relationship with status of viral hepatitis. J Surg Oncol. 2007;96:487–92.CrossRefPubMed Nanashima A, Abo T, Sumida Y, Takeshita H, Hidaka S, Furukawa K, et al. Clinicopathological characteristics of patients with hepatocellular carcinoma after hepatectomy: relationship with status of viral hepatitis. J Surg Oncol. 2007;96:487–92.CrossRefPubMed
12.
go back to reference Kondo K, Chijiiwa K, Funagayama M, Kai M, Otani K, Ohuchida J. Differences in long-term outcome and prognostic factors according to viral status in patients with hepatocellular carcinoma treated by surgery. J Gastrointest Surg. 2008;12:468–76.CrossRefPubMed Kondo K, Chijiiwa K, Funagayama M, Kai M, Otani K, Ohuchida J. Differences in long-term outcome and prognostic factors according to viral status in patients with hepatocellular carcinoma treated by surgery. J Gastrointest Surg. 2008;12:468–76.CrossRefPubMed
13.
go back to reference Cucchetti A, Piscaqlia F, Caturelli E, Benvegnù L, Vivarelli M, Ercolani G, et al. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol. 2009;16:413–22.CrossRefPubMed Cucchetti A, Piscaqlia F, Caturelli E, Benvegnù L, Vivarelli M, Ercolani G, et al. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol. 2009;16:413–22.CrossRefPubMed
14.
go back to reference Eguchi S, Takatsuki M, Hidaka M, Soyama A, Tomonaga T, Muraoka I, et al. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection. World J Surg. 2010;34:1034–8.CrossRefPubMed Eguchi S, Takatsuki M, Hidaka M, Soyama A, Tomonaga T, Muraoka I, et al. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection. World J Surg. 2010;34:1034–8.CrossRefPubMed
15.
go back to reference Shinkawa H, Uenishi T, Takemura S, Ohba K, Ogawa M, Ichikawa T, et al. Risk factors for postoperative recurrence of non-B non-C hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2010;17:291–5.CrossRefPubMed Shinkawa H, Uenishi T, Takemura S, Ohba K, Ogawa M, Ichikawa T, et al. Risk factors for postoperative recurrence of non-B non-C hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2010;17:291–5.CrossRefPubMed
16.
go back to reference Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10–24.PubMedCentralCrossRefPubMed Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10–24.PubMedCentralCrossRefPubMed
17.
go back to reference Wakai T, Shirai Y, Yokoyama N, Nagakura S, Hatakeyama K. Hepatitis viral status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma. Eur J Surg Oncol. 2003;29:266–71.CrossRefPubMed Wakai T, Shirai Y, Yokoyama N, Nagakura S, Hatakeyama K. Hepatitis viral status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma. Eur J Surg Oncol. 2003;29:266–71.CrossRefPubMed
18.
go back to reference Umemura T, Kiyosawa K. Epidemiology of hepatocellular carcinoma in Japan. Hepatol Res. 2007;37:S95–100.CrossRefPubMed Umemura T, Kiyosawa K. Epidemiology of hepatocellular carcinoma in Japan. Hepatol Res. 2007;37:S95–100.CrossRefPubMed
19.
go back to reference Takuma Y, Nouso K, Makino Y, Gotoh T, Toshikuni N, Morimoto Y, et al. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria. J Gastroenterol Hepatol. 2011;26:1417–24.PubMed Takuma Y, Nouso K, Makino Y, Gotoh T, Toshikuni N, Morimoto Y, et al. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria. J Gastroenterol Hepatol. 2011;26:1417–24.PubMed
20.
go back to reference Tokushige K, Hashimoto E, Horie Y, Taniai M, Higuchi S. Hepatocellular carcinoma based on cryptogenic liver disease: the most common non-viral hepatocellular carcinoma in patients aged over 80 years. Hepatol Res. 2015;45:441–7.CrossRefPubMed Tokushige K, Hashimoto E, Horie Y, Taniai M, Higuchi S. Hepatocellular carcinoma based on cryptogenic liver disease: the most common non-viral hepatocellular carcinoma in patients aged over 80 years. Hepatol Res. 2015;45:441–7.CrossRefPubMed
Metadata
Title
Long-term prognosis after resection of cryptogenic hepatocellular carcinoma
Authors
Yu Ohkura
Kazunari Sasaki
Masamichi Matsuda
Masaji Hashimoto
Goro Watanabe
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Surgery / Issue 1/2015
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-015-0099-9

Other articles of this Issue 1/2015

BMC Surgery 1/2015 Go to the issue